SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-002351
Filing Date
2021-02-09
Accepted
2021-02-09 16:59:19
Documents
2
Period of Report
2021-02-09
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20210209_8k.htm 8-K 28669
2 EXHIBIT 10.1 ex_225425.htm EX-10.1 42048
  Complete submission text file 0001437749-21-002351.txt   71929
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 21607365
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences